Literature DB >> 3918194

Does long-term home parenteral nutrition in adult patients cause chronic liver disease?

B A Bowyer, C R Fleming, J Ludwig, J Petz, D B McGill.   

Abstract

Sixty patients with gut failure were treated with home parenteral nutrition for 2000 patient months. Fifty-one of these 60 patients had either no abnormalities or mild and transient elevations of their liver chemistries and did not have liver biopsies. Nine (15%) of 60 patients had abnormalities of liver tests that persisted from 8 to 95 months (median, 18 months) which prompted one or more liver biopsies per patient. Three patients had prolonged jaundice, one died of hepatic encephalopathy, and another with protracted intrahepatic cholestasis died following a biliary tract exploration. A third patient remains ill with signs and symptoms of chronic liver disease. Steatohepatitis was found in eight of the nine patients and was characterized by centrilobular and midzonal microvesicular and macrovesicular fatty changes with fat cysts, focal necrosis, and mixed inflammatory infiltrates. Centrilobular fibrosis was present in three patients and evidence of nodular regeneration in one. In the three patients demonstrating cholestasis, bile pigment was identified both in hepatocytes and canaliculi. Ceroid pigment in Kupffer cells was a consistent finding and much more severe than expected from the mildness of the hepatitis. Persistent abnormalities of liver chemistries in nine patients and progressive liver disease while receiving home parenteral nutrition in three patients are quite worrisome and suggest that home parenteral nutrition-associated steatohepatitis with or without cholestasis may progress to chronic liver disease.

Entities:  

Mesh:

Year:  1985        PMID: 3918194     DOI: 10.1177/014860718500900111

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  9 in total

Review 1.  Complications of long-term home total parenteral nutrition: their identification, prevention and treatment.

Authors:  A L Buchman
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

Review 2.  Specific topics and complications of parenteral nutrition.

Authors:  Eduardo E Montalvo-Jave; José L Zarraga; Michael G Sarr
Journal:  Langenbecks Arch Surg       Date:  2007-01-13       Impact factor: 3.445

Review 3.  Parenteral nutrition: ethical and legal considerations.

Authors:  G M Sayers; D A J Lloyd; S M Gabe
Journal:  Postgrad Med J       Date:  2006-02       Impact factor: 2.401

4.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

Review 5.  Comprehensive care of the patient with gut failure: present and future.

Authors:  C R Fleming
Journal:  Trans Am Clin Climatol Assoc       Date:  1987

Review 6.  Short bowel syndrome: parenteral nutrition versus intestinal transplantation. Where are we today?

Authors:  Mark DeLegge; Mohammad M Alsolaiman; English Barbour; Samah Bassas; M Faisal Siddiqi; Nicole M Moore
Journal:  Dig Dis Sci       Date:  2007-02-16       Impact factor: 3.199

7.  Effect of ursodeoxycholic acid on hepatic steatosis in rats.

Authors:  Abdullah Okan; Huseyin Astarcioglu; Ethem Tankurt; Ozgul Sagol; Emel Altekin; Ibrahim Astarcioglu; Omur Gonen
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

8.  Short bowel patients treated for two years with glucagon-like peptide 2 (GLP-2): compliance, safety, and effects on quality of life.

Authors:  P B Jeppesen; P Lund; I B Gottschalck; H B Nielsen; J J Holst; J Mortensen; S S Poulsen; B Quistorff; P B Mortensen
Journal:  Gastroenterol Res Pract       Date:  2009-07-05       Impact factor: 2.260

9.  Disturbances in essential fatty acid metabolism in patients receiving long-term home parenteral nutrition.

Authors:  Pei-Ra Ling; Mario Ollero; Lalita Khaodhiar; Karen McCowen; Mary Keane-Ellison; Ann Thibault; Nicholas Tawa; Bruce R Bistrian
Journal:  Dig Dis Sci       Date:  2002-08       Impact factor: 3.199

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.